10-Q Filing

BNB PLUS CORP. CIK: 744452 Q1 2024

Filing Information

Form Type	10-Q
Accession Number	`0001410578-24-000021`
Period End Date	20231231
Filing Date	20240208
Fiscal Year	2024
Fiscal Period	Q1
XBRL Instance	apdn-20231231x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 81 Income Statement 39 Cash Flow Statement 44 Stockholders Equity 18

Balance Sheet 81 line items

Line Item	Tag	Value	Unit	Period
Allowance on accounts receivable	`AllowanceForDoubtfulAccountsReceivableCurrent`	$75.00K	USD	Point-in-time
Allowance on accounts receivable	`AllowanceForDoubtfulAccountsReceivableCurrent`	$75.00K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.15M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.36M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.36M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Accounts receivable, net of allowance of $75,000 at December 31, 2023 and September 30, 2023, respectively	`AccountsReceivableNetCurrent`	$255.50K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net of allowance of $75,000 at December 31, 2023 and September 30, 2023, respectively	`AccountsReceivableNetCurrent`	$450.76K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$377.29K	USD	Point-in-time
Inventories	`InventoryNet`	$330.03K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$402.95K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$389.24K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$4.59M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$8.13M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$838.27K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	13.72M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	13.72M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$539.32K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	13.66M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	13.66M	shares	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$750.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$750.00K	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$2.70M	USD	Point-in-time
Intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$2.70M	USD	Point-in-time
Operating right of use asset	`OperatingLeaseRightOfUseAsset`	$1.24M	USD	Point-in-time
Operating right of use asset	`OperatingLeaseRightOfUseAsset`	$1.12M	USD	Point-in-time
Capitalized transaction costs	`CapitalizedTransactionCostsForAssetPurchaseTransaction`	$217.55K	USD	Point-in-time
Total assets	`Assets`	$9.91M	USD	Point-in-time
Total assets	`Assets`	$13.65M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.02M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.27M	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	$498.60K	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	$510.03K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$54.03K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$76.44K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.85M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.59M	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$31.47K	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$31.47K	USD	Point-in-time
Deferred revenue, long term	`ContractWithCustomerLiabilityNoncurrent`	$228.00K	USD	Point-in-time
Deferred revenue, long term	`ContractWithCustomerLiabilityNoncurrent`	$194.00K	USD	Point-in-time
Operating lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$739.16K	USD	Point-in-time
Operating lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$607.29K	USD	Point-in-time
Deferred tax liability, net	`DeferredIncomeTaxLiabilitiesNet`	$684.12K	USD	Point-in-time
Deferred tax liability, net	`DeferredIncomeTaxLiabilitiesNet`	$684.12K	USD	Point-in-time
Warrants classified as a liability	`CommonWarrantLiabilityNoncurrent`	$1.65M	USD	Point-in-time
Warrants classified as a liability	`CommonWarrantLiabilityNoncurrent`	$4.29M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.78M	USD	Point-in-time
Total liabilities	`Liabilities`	$8.78M	USD	Point-in-time
Commitments and contingencies (Note G)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note G)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of Decenber 31, 2023 and September 30 2023, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of Decenber 31, 2023 and September 30 2023, respectively	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of December 31, 2023 and September 30, 2023, 13,721,820 and 13,658,520 shares issued and outstanding as of December 31, 2023 and September 30, 2023, respectively	`CommonStockValue`	$13.72K	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of December 31, 2023 and September 30, 2023, 13,721,820 and 13,658,520 shares issued and outstanding as of December 31, 2023 and September 30, 2023, respectively	`CommonStockValue`	$13.66K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$307.38M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$307.85M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-303.63M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-302.45M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity	`StockholdersEquity`	$4.95M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity	`StockholdersEquity`	$4.23M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-103.93K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-78.75K	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.13M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.91M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.16M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.87M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$9.91M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$13.65M	USD	Point-in-time

Income Statement 39 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$5.26M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$891.16K	USD	1 Quarter
Total cost of revenues	`CostOfRevenue`	$660.07K	USD	1 Quarter
Total cost of revenues	`CostOfRevenue`	$2.89M	USD	1 Quarter
Gross profit	`GrossProfit`	$2.38M	USD	1 Quarter
Gross profit	`GrossProfit`	$231.10K	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.63M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.08M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$935.82K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$971.30K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.60M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$4.02M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-1.22M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-3.79M	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$33.32K	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$3.69K	USD	1 Quarter
Unrealized gain (loss) on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$2.64M	USD	1 Quarter
Unrealized gain (loss) on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-2.64M	USD	1 Quarter
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$8.85K	USD	1 Quarter
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$-13.54K	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.84M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.13M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-3.84M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-1.13M	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-25.18K	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-874.00	USD	1 Quarter
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-3.84M	USD	1 Quarter
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-1.11M	USD	1 Quarter
Deemed dividend related to warrant modifications	`DeemedDividendRelatedToWarrantModifications`	$77.76K	USD	1 Quarter
NET LOSS attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.84M	USD	1 Quarter
NET LOSS attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.18M	USD	1 Quarter
Net loss per share attributable to common stockholders - basic	`EarningsPerShareBasic`	$-0.30	USD	1 Quarter
Net loss per share attributable to common stockholders - basic	`EarningsPerShareBasic`	$-0.09	USD	1 Quarter
Net loss per share attributable to common stockholders - diluted	`EarningsPerShareDiluted`	$-0.30	USD	1 Quarter
Net loss per share attributable to common stockholders - diluted	`EarningsPerShareDiluted`	$-0.09	USD	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.91M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	13.67M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.91M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	13.67M	shares	1 Quarter

Cash Flow Statement 44 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-3.84M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.13M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$338.92K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$298.95K	USD	1 Quarter
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$6.08K	USD	1 Quarter
Unrealized (gain) loss on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$2.64M	USD	1 Quarter
Unrealized (gain) loss on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-2.64M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$93.75K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$340.70K	USD	1 Quarter
Change in provision for bad debts	`ProvisionForDoubtfulAccounts`	$-290.02K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$695.91K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$195.25K	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$47.26K	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-125.23K	USD	1 Quarter
Prepaid expenses, other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$13.71K	USD	1 Quarter
Prepaid expenses, other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-133.37K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-586.24K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-383.42K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$-289.68K	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$11.60K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.38M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.76M	USD	1 Quarter
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$45.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$45.00K	USD	1 Quarter
Net proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$45.57K	USD	1 Quarter
Capitalized transaction costs	`PaymentsOfStockIssuanceCosts`	$80.64K	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-35.08K	USD	1 Quarter
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.79M	USD	1 Quarter
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.34M	USD	1 Quarter
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.11M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.88M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.22M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.11M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.88M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.22M	USD	Point-in-time
Cash paid during period for interest	`InterestPaidNet`	-	USD	1 Quarter
Cash paid during period for interest	`InterestPaidNet`	-	USD	1 Quarter
Cash paid during period for income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Cash paid during period for income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Capitalized transaction costs included in accounts payable	`CapitalizedTransactionCostsIncludedInAccountsPayable`	$136.91K	USD	1 Quarter
Deemed dividend warrant modifications	`DeemedDividendWarrantModifications`	$77.76K	USD	1 Quarter
Property and equipment acquired and included in accounts payable	`PropertyPlantAndEquipmentAcquiredAndIncludedInAccountsPayable`	$20.62K	USD	1 Quarter

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.13M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.91M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.16M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.87M	USD	Point-in-time
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	13.66M	shares	Point-in-time
Beginning Balance (in shares)	`CommonStockSharesOutstanding`	13.66M	shares	Point-in-time
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$340.70K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$93.75K	USD	1 Quarter
Common stock issued in ATM, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$-45.57K	USD	1 Quarter
Common stock issued in ATM, net of offering costs (In shares)	`StockIssuedDuringPeriodSharesNewIssues`	61,200.00	shares	1 Quarter
Net loss	`ProfitLoss`	$-3.84M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.13M	USD	1 Quarter
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.13M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.91M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.16M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$4.87M	USD	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	13.66M	shares	Point-in-time
Ending Balance (in shares)	`CommonStockSharesOutstanding`	13.66M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.